{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1555643", "DateCompleted": {"Year": "1992", "Month": "05", "Day": "07"}, "DateRevised": {"Year": "2019", "Month": "06", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0014-2999", "JournalIssue": {"Volume": "212", "Issue": "1", "PubDate": {"Year": "1992", "Month": "Feb", "Day": "25"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice.", "Pagination": {"StartPage": "87", "EndPage": "92", "MedlinePgn": "87-92"}, "Abstract": {"AbstractText": ["The mechanism was studied by which isoliquiritigenin, a new aldose reductase inhibitor purified from licorice (Glycyrrhizae radix), inhibits platelet aggregation. This new agent significantly inhibited the phosphorylation of 40,000- and 20,000-dalton proteins, and inhibited the formation of 12 (S)-hydroxy-5,8,10-heptadecatrienoic acid, 12-hydroxyeicosatetraenoic acid and thromboxane B2. The inhibitory effect of isoliquiritigenin on platelet aggregation in vitro was comparable to that of aspirin. Our findings may indicate that isoliquiritigenin elicits an anti-platelet action by inhibiting not only cyclooxygenase but also lipoxygenase or peroxidase activity in platelets. Isoliquiritigenin also showed an anti-platelet action in vivo. Isoliquiritigenin appears to be the only aldose reductase inhibitor with a significant anti-platelet action. Since the hyperaggregability of platelets has been implicated in the pathogenesis of diabetic complications, isoliquiritigenin may offer a unique benefit as an aldose reductase inhibitor."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Third Department of Internal Medicine, University of Yamanashi Medical School, Japan."}], "LastName": "Tawata", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Aida", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Noguchi", "ForeName": "T", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ozaki", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kume", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sasaki", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Chin", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Onaya", "ForeName": "T", "Initials": "T"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Chalcones"}, {"RegistryNumber": "0", "NameOfSubstance": "Fatty Acids, Unsaturated"}, {"RegistryNumber": "0", "NameOfSubstance": "Hydroxyeicosatetraenoic Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Platelet Aggregation Inhibitors"}, {"RegistryNumber": "50683-78-8", "NameOfSubstance": "12-hydroxy-5,8,10-heptadecatrienoic acid"}, {"RegistryNumber": "54397-85-2", "NameOfSubstance": "Thromboxane B2"}, {"RegistryNumber": "5S5A2Q39HX", "NameOfSubstance": "Chalcone"}, {"RegistryNumber": "B9CTI9GB8F", "NameOfSubstance": "isoliquiritigenin"}, {"RegistryNumber": "EC 1.1.1.21", "NameOfSubstance": "Aldehyde Reductase"}], "MeshHeadingList": [{"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Aldehyde Reductase"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Blood Platelets"}, {"QualifierName": ["metabolism"], "DescriptorName": "Blood Proteins"}, {"QualifierName": ["analogs & derivatives", "chemistry", "pharmacology"], "DescriptorName": "Chalcone"}, {"QualifierName": [], "DescriptorName": "Chalcones"}, {"QualifierName": ["blood"], "DescriptorName": "Fatty Acids, Unsaturated"}, {"QualifierName": ["chemistry"], "DescriptorName": "Glycyrrhiza"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood"], "DescriptorName": "Hydroxyeicosatetraenoic Acids"}, {"QualifierName": [], "DescriptorName": "Molecular Weight"}, {"QualifierName": ["drug effects"], "DescriptorName": "Phosphorylation"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Platelet Aggregation Inhibitors"}, {"QualifierName": ["blood"], "DescriptorName": "Thromboxane B2"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1992", "Month": "2", "Day": "25"}, {"Year": "1992", "Month": "2", "Day": "25", "Hour": "0", "Minute": "1"}, {"Year": "1992", "Month": "2", "Day": "25", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1555643", "10.1016/0014-2999(92)90076-g", "0014-2999(92)90076-G"]}}]}